CURNEX- guaifenesin 400mg tablet 
Wittman Pharma, Inc.

----------

CuraNEX

Directions

Warnings

Ask a doctor before use if you have * persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema * cough accompanied by excessive phlegm (mucus)

Stop use and ask a doctor if * cough lasts more than 7 days, comes back, or is accompanied by fever, rash or persistent headache. These could be signs of a serious illness.

If pregnant or breast feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Inactive Ingredients: Magnesium Stearate, Microcrystalline Cellulose, Sodium Starch Glycolate

Keep out of reach of children. In case of overdose, get

medical help or contact a Poison Control Center right away.

Purpose: Expectorant

Guaifenesin 400 mg

CuraNEX Label

CURNEX 
guaifenesin 400mg tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:83335-003
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ) GUAIFENESIN400 mg
Inactive Ingredients
Ingredient NameStrength
MAGNESIUM STEARATE (UNII: 70097M6I30)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
SODIUM STARCH GLYCOLATE TYPE A (UNII: H8AV0SQX4D)  
Product Characteristics
ColorwhiteScore2 pieces
ShapeROUNDSize13mm
FlavorImprint Code GN
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:83335-003-01100 in 1 BOTTLE; Type 0: Not a Combination Product03/01/2024
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01203/01/2024
Labeler - Wittman Pharma, Inc. (830980947)
Establishment
NameAddressID/FEIBusiness Operations
Wittman Pharma, Inc.830980947analysis(83335-003) , manufacture(83335-003) , label(83335-003)

Revised: 3/2024
Document Id: 132b9415-7461-c981-e063-6394a90ae3de
Set id: 132b9415-7460-c981-e063-6394a90ae3de
Version: 1
Effective Time: 20240308
 
Wittman Pharma, Inc.